Literature DB >> 18486910

Comparison in the effects of IL-2, IL-12, IL-15 and IFNalpha on gene regulation of granzymes of human NK cell line NK-92.

Bin Zhang1, Jian Zhang, Zhigang Tian.   

Abstract

Serine protease granzymes (GZM) are key effector molecules of granule-mediated cytotoxicity of NK cell, but the requirement for their expression regulation remains largely undefined. In this study, it was showed that IL-2, IL-12, IL-15 and IFNalpha differently regulated the expression of granzymes in NK cells. Although IL-2, IL-12, IL-15 and IFNalpha exerted overlapping positive effects on transcripts of GZM-A and GZM-B, the augment extent and the peaked time course were different for each GZM member after stimulation with these cytokines. Additionally, only IFNalpha up-regulated the transcription of GZM-K, while IL-15 dramatically down-regulated the GZM-H mRNA level. The protein levels of GZM-B and cytotoxicity of NK-92 cells in response to IL-2 or IFNalpha were analyzed, the results showed a positive relationship between cytotoxicity and GZM-B expression level. Together, these findings illustrated that IL-2, IL-12, IL-15 and IFNalpha exerted differential regulating effects on granzyme genes of NK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486910     DOI: 10.1016/j.intimp.2008.03.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  12 in total

1.  Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.

Authors:  Felix N Toka; Charles K Nfon; Harry Dawson; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

2.  HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.

Authors:  Longyan Wu; Cai Zhang; Jian Zhang
Journal:  Cell Mol Immunol       Date:  2011-06-27       Impact factor: 11.530

Review 3.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

4.  Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Authors:  Kerstin A Stegmann; Niklas K Björkström; Sandra Ciesek; Sebastian Lunemann; Jerzy Jaroszewicz; Johannes Wiegand; Phillipp Malinski; Lynn B Dustin; Charles M Rice; Michael P Manns; Thomas Pietschmann; Markus Cornberg; Hans-Gustaf Ljunggren; Heiner Wedemeyer
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

5.  The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.

Authors:  Rossana Trotta; David Ciarlariello; Jessica Dal Col; Hsiaoyin Mao; Li Chen; Edward Briercheck; Jianhua Yu; Jianying Zhang; Danilo Perrotti; Michael A Caligiuri
Journal:  Blood       Date:  2010-12-14       Impact factor: 22.113

Review 6.  Engineering IL-2 for immunotherapy of autoimmunity and cancer.

Authors:  Rosmely Hernandez; Janika Põder; Kathryn M LaPorte; Thomas R Malek
Journal:  Nat Rev Immunol       Date:  2022-02-25       Impact factor: 108.555

7.  Generation of CD2(+)CD8(+) NK Cells from c-kit(+) Bone Marrow Cells in Porcine.

Authors:  Kyu Hee Lim; Ji-Hui Han; Yoon Seok Roh; Bumseok Kim; Jung-Kee Kwon; Myoung Jo You; Ho Jae Han; Sohail Ejaz; Chang-Won Kang; Jong-Hoon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-06-26       Impact factor: 2.016

8.  Transient blocking of NK cell function with small molecule inhibitors for helper dependant adenoviral vector-mediated gene delivery.

Authors:  Manjunatha Ankathatti Munegowda; Jim Hu
Journal:  Cell Biosci       Date:  2015-06-11       Impact factor: 7.133

9.  COTRASIF: conservation-aided transcription-factor-binding site finder.

Authors:  Bogdan Tokovenko; Rostyslav Golda; Oleksiy Protas; Maria Obolenskaya; Anna El'skaya
Journal:  Nucleic Acids Res       Date:  2009-03-05       Impact factor: 16.971

10.  Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.

Authors:  Joel D Pearson; Jingxi Zhang; Zuoqiao Wu; Kayla D Thew; Katelynn J Rowe; Julinor T C Bacani; Robert J Ingham
Journal:  Mol Cancer       Date:  2014-08-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.